Mad Money with Jim Cramer - MAD CAP RECAP - The Official Mad Money Blog
RSS FEED
FEATURED SLIDESHOW
Who Is The Worst CEO?Mad Money needed new inductees for its
Wall of Shame, so we asked viewers for
nominations.
RECENT POSTS
- Time to Buy Treasurys?
- Lightning Round: Las Vegas Sands, ADC Telecom, Satyam Computer and More
- Lightning Round OT: Knight Capital, Ebix and More
- Is Lear, Back From Bankruptcy, a Buy?
- Sanofi-Aventis Falling Off a Patent Cliff?
- Cramer: Your Thanksgiving Week Game Plan
- Cramer: Next Week Should Define Rest of ‘09
- Mad Money: Mad Mail: Buy RIM or Apple?
- Lightning Round: Cisco Systems, Citigroup, Baidu.com and More
- Lightning Round OT: Martek Biosciences, Valmont Industries and More
MAD MONEY FEATURES
PODCASTSWatch the Lightning Round whenever and wherever you want.
OFFICIAL MAD MONEY WIDGETGrab this all-in-one application and get recaps of the show sent right to your desktop or blog.
CRAMERS SOUNDBOARDAdmit it: You've always wanted to hit the "They
know nothing!" button. Here’s your chance.
CHECK OUT OUR PHOTOSCheck out Cramer on set, back to school, behind the scenes and more.
SHOP FOR MAD MERCHANDISEBuy Cramer books, bobbleheads and other Mad Money merchandise.
RING TONESPick up the phone! It's Cramer! New Mad Money sounds for your cell phone.
TEXT MESSAGE ALERTMad Money's mobile. Get show highlights sent to your phone.
Text Size 
Web Editor, Mad Money
 |
The general public has started trading fixed-income securities for stocks, Cramer said during Monday’s Stop Trading!. He pointed to Boeing and Merck, whose share prices “are flying,” as proof.
There’s been little good news from either company, Cramer said, but that hasn’t stopped Boeing [BA
Loading...
()
] and Merck [MRK
Loading...
()
] from pushing higher. That’s often the case when new money from retail investors floods the market, usually the S&P 500. Cramer also noted that the run since last spring happened largely without this influx of cash.
“The retail investor hasn’t touched this market at all,” the Mad Money host said.
Intel’s [INTC
Loading...
()
] dividend boost was a message to Wall Street, Cramer said. It read, “You don’t understand how good things are.” The stock declined after the company’s most recent earnings report, and he thinks unnecessarily so. Intel responded so investors would know it had plenty of cash on hand in anticipation of the AMD [AMD
Loading...
()
] settlement, and that margins and earnings were on the rise.
“I really like Intel here,” Cramer said.
He added that Dell’s [DELL
Loading...
()
] upgrade was good for Intel, too, and Microsoft [MSFT
Loading...
()
] can’t be up without taking Intel with it.
Lastly, Cramer endorsed Bristol-Myers Squibb [BMY
Loading...
()
], saying that Immunogen [IMGN
Loading...
()
], Exelixis [EXEL
Loading...
()
] and Allos Therapeutics [ALTH
Loading...
()
] make natural acquisition targets to extend the company’s cancer franchise. He called CEO James Cornelius “money in the bank.”
Cramer’s charitable trust owns Bristol-Myers Squibb.
Call Cramer: 1-800-743-CNBC
Questions for Cramer?
Questions, comments, suggestions for the Mad Money website?
Data is a real-time snapshot *Data is delayed at least 15 minutes